申请人:Efamol Holdings plc
公开号:US05216142A1
公开(公告)日:1993-06-01
Anti-virals wherein a linoleyl, gamma-linolenyl or other unsaturated long chain fatty acyl group is borne directly on a hydroxy or amino group of the sugar/sugar analogue or heterocyclic moiety of a nucleoside or nucleoside analogue.
抗病毒药物,其中亚油酰基、γ-亚麻酰基或其他不饱和长链脂肪酰基直接承载在核苷或核苷类似物的糖/糖类似物或杂环基团的羟基或氨基上。